Linked Data API

Show Search Form

Search Results

1126869
unstar this property registered interest false more like this
star this property date less than 2019-05-15more like thismore than 2019-05-15
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading NHS: Pensions more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what assessment he has made of the effect of the introduction of the (a) new NHS pension scheme in 2015, (b) reduction of the annual allowance for pension growth, (c) subsequent tapering of that allowance and (d) other cumulative changes in recent years to the NHS pension scheme on the (i) level of hours worked by practitioners and (ii) level of practitioner morale. more like this
star this property tabling member constituency Ayr, Carrick and Cumnock more like this
star this property tabling member printed
Bill Grant more like this
star this property uin 254864 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2019-05-23more like thismore than 2019-05-23
star this property answer text <p>The 2015 NHS Pension Scheme is valuable part of staff reward packages and remains one of the best schemes available. The reforms to public service pensions ensured that schemes are sustainable and the costs are fair to both staff and the taxpayer.</p><p>Data is not collected on the impact of the new National Health Service pension scheme, other cumulative changes, or the annual allowance on the level of hours worked by practitioners, or practitioner morale.</p><p>The Department recognises that the tapered annual allowance may contribute to decisions by NHS staff to retire early or limit their NHS commitments. The Government is listening carefully to concerns raised by senior doctors and NHS employers about the impact of tapered annual allowance.</p><p>The Department has sought to make available to NHS Pension Scheme members all possible flexibility under Her Majesty’s Revenue and Customs legislation and the current fiscal framework for public sector pension schemes. The Chancellor is considering the case for further flexibility in the NHS Pension Scheme.</p>
star this property answering member constituency Wimbledon more like this
star this property answering member printed Stephen Hammond more like this
star this property question first answered
less than 2019-05-23T12:27:22.64Zmore like thismore than 2019-05-23T12:27:22.64Z
star this property answering member
1585
unstar this property label Biography information for Stephen Hammond more like this
star this property tabling member
4605
star this property label Biography information for Bill Grant remove filter
982917
unstar this property registered interest false more like this
star this property date less than 2018-10-08more like thismore than 2018-10-08
star this property answering body
Department of Health and Social Care more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health and Social Care more like this
star this property answering dept sort name Health and Social Care remove filter
star this property hansard heading Hip Replacements: Safety more like this
star this property house id 1 more like this
star this property legislature
25259
star this property pref label House of Commons more like this
star this property question text To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the (a) testing and (b) certification procedures for (i) metal and (ii) other compositions of hip replacements fitted as medical devices by the NHS ensure that such devices are safe for patients; and if he will make a statement. more like this
star this property tabling member constituency Ayr, Carrick and Cumnock more like this
star this property tabling member printed
Bill Grant more like this
star this property uin 176549 more like this
star this property answer
answer
star this property is ministerial correction false more like this
star this property date of answer less than 2018-10-16more like thismore than 2018-10-16
star this property answer text <p>All medical devices placed on the United Kingdom market must comply with the European Union Medical Devices Directive 93/42/EEC (MDD). The European Conformity (CE) mark for a device is placed on a product by a manufacturer to attest to its compliance with the safety, quality and performance requirements of the MDD.</p><p> </p><p>For higher risk devices, including hip replacement implants, manufacturers must have the product’s safety and performance assessed by an independent certification body, called a notified body, before the CE mark can be affixed.</p><p> </p><p>A notified body’s tasks will vary depending on the classification of the products concerned, but typical activities include an examination of the design dossier relating to each type of product, an assessment of the full technical information, and manufacturer inspections. Under the MDD, manufacturers are required to have clinical and safety data to support their performance claims for the device, which is also assessed by the notified body.</p><p> </p><p>Once a device is placed on the market, the manufacturer is required to continually monitor the performance of their device, submit vigilance reports to the Medicines and Healthcare products Regulatory Agency (MHRA) when incidents occur involving their device and take appropriate safety action when required. Additionally, the MHRA monitors adverse incident reported though the Yellow Card reporting system. Adverse incident reports can be submitted to the MHRA by members of the public, healthcare professionals and the device manufacturer.</p><p> </p><p>Furthermore, the new European Union Medical Devices Regulation 2017/745, which entered into force in May 2017, has introduced more stringent requirements from manufacturers to ensure a high level of patient safety. These include increased scrutiny by notified bodies, particularly for higher risk devices, new standards for clinical evidence and more rigorous vigilance reporting requirements.</p>
star this property answering member constituency West Suffolk more like this
star this property answering member printed Matt Hancock more like this
star this property question first answered
less than 2018-10-16T13:56:24.34Zmore like thismore than 2018-10-16T13:56:24.34Z
star this property answering member
4070
unstar this property label Biography information for Matt Hancock more like this
star this property tabling member
4605
star this property label Biography information for Bill Grant remove filter